Step 1 topics → Hematology and Oncology → Hematopoiesis and Lineage Differentiation

Hematopoiesis and Lineage Differentiation

USMLE Step 1 trap: Misassigns NK cells to the myeloid lineage instead of the lymphoid lineage. NK cells are lymphoid-lineage cells derived from the common lymphoid progenitor, along with T and B cells.

Hematopoiesis is the process by which all blood cells are generated from a single hematopoietic stem cell (HSC), and USMLE Step 1 tests this in three main ways: lineage classification, developmental site sequence, and clinical application. The most common lineage error: students classify NK cells as myeloid because they're innate cytotoxic cells. NK cells are lymphoid, derived from the common lymphoid progenitor alongside T and B cells — lineage is determined by progenitor origin, not function. Getting that wrong means misclassifying cells in combined immunodeficiency questions. The developmental sequence (yolk sac → fetal liver → bone marrow) and the CD34 marker for stem cell transplant selection are the other two high-yield angles.

The trickiest parts are the cells that feel like they belong to one lineage but don't. NK cells are the classic trap: they kill things, they look innate, students slot them with monocytes and neutrophils in the myeloid bucket. Wrong — NK cells are lymphoid. The developmental site sequence is another high-yield pitfall. Most students know liver and bone marrow but forget the yolk sac comes first, and that matters when a question asks about the earliest site of embryonic blood formation.

USMLE Step 1 also tests the CD34 marker in the context of stem cell transplantation — not as isolated trivia, but as a clinical tool used to select and purify HSCs before infusion. Extramedullary hematopoiesis is the applied angle: when bone marrow is destroyed or replaced (myelofibrosis, severe hemolytic anemia), the liver and spleen reactivate fetal-era hematopoiesis, causing massive organomegaly. That connection between pathology and compensatory physiology is exactly the kind of integration the exam rewards.

From real student decks
84%have cards covering this topic
57%have mature cards

Common misconceptions

Common mistake
Wrong: NK cells arise from the myeloid progenitor alongside monocytes and granulocytes.
Right: NK cells are lymphoid-lineage cells derived from the common lymphoid progenitor, along with T and B cells.
NK cells feel innate and cytotoxic, which makes students group them with macrophages and neutrophils — but lineage is determined by progenitor origin, not function. NK cells derive from the common lymphoid progenitor alongside T and B cells, making them lymphoid-lineage by definition. On the exam, if you see a question about lymphoid progenitor outputs or a patient with combined T/B/NK cell deficiency, NK cells belong in the lymphoid column, not the myeloid one.
Common mistake
Wrong: The liver is the first site of fetal hematopoiesis.
Right: The yolk sac is the first site of hematopoiesis (weeks 3–8), followed by the liver, then bone marrow.
The liver is prominent in fetal hematopoiesis and easy to remember, which is exactly why it gets misidentified as the first site. But the yolk sac initiates blood cell production starting around week 3, well before the liver takes over in the second trimester. The sequence — yolk sac → liver → bone marrow — is the testable fact, and 'first' is the word Step 1 will use to probe whether you know the yolk sac comes before the liver.
Common mistake
Wrong: CD34 is a marker of mature T cells rather than hematopoietic stem cells.
Right: CD34 is the surface marker identifying HSCs and is used to select stem cells for transplantation.
CD34 is not a T-cell marker — mature T cells are identified by CD3, CD4, or CD8. CD34 is expressed on hematopoietic stem and progenitor cells, and its clinical relevance is in transplantation: labs use CD34 selection to purify HSCs from donor blood or marrow before infusing them into a recipient. If a vignette mentions stem cell transplant and asks what marker is used to isolate the cells, the answer is CD34.
Common mistake
Gap: Unaware that extramedullary hematopoiesis is a compensatory response to marrow failure or destruction
Extramedullary hematopoiesis in liver and spleen is triggered by conditions that destroy or replace bone marrow (e.g., myelofibrosis, severe hemolytic anemia), and can cause massive organomegaly.
Extramedullary hematopoiesis isn't random — it's a compensatory response that occurs specifically when the bone marrow can no longer do its job, either because it's been replaced by fibrosis (myelofibrosis), infiltrated by tumor, or overwhelmed by demand (severe chronic hemolytic anemia). The liver and spleen essentially reactivate their fetal hematopoietic role, and the result is massive organomegaly. On the exam, unexplained hepatosplenomegaly plus a history of marrow pathology should immediately trigger this diagnosis.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know which specific cell types arise from the common myeloid progenitor (granulocytes, monocytes, erythrocytes, megakaryocytes) versus the common lymphoid progenitor (T cells, B cells, NK cells) — the exam will give you a cell and ask you to place it correctly in the lineage tree.
  2. Know the chronological sequence of hematopoietic sites during fetal development: yolk sac (weeks 3–8) → fetal liver → bone marrow (takes over by birth), and understand what triggers a return to earlier sites after birth.
  3. Know that CD34 is the surface marker that identifies hematopoietic stem cells, and understand its clinical application as the selection marker used to isolate HSCs for bone marrow transplantation.
  4. Recognize extramedullary hematopoiesis as a compensatory response to bone marrow failure or replacement (e.g., myelofibrosis, severe hemolytic anemia), and connect it mechanistically to hepatosplenomegaly seen on exam vignettes.

Can you avoid these mistakes?

A patient is found to have massive splenomegaly. Bone marrow biopsy shows replacement of normal marrow with fibrotic tissue. What is the mechanism of the splenomegaly, and what fetal process has been reactivated?
Which of the following cell types is derived from the common lymphoid progenitor: neutrophil, NK cell, monocyte, or megakaryocyte? Explain why the answer might seem counterintuitive.
A technician is preparing a stem cell graft for allogeneic bone marrow transplant and needs to select HSCs from the donor's peripheral blood. Which surface marker do they use, and what does that marker identify?
A 3-week-old premature infant in the NICU is found to have nucleated RBCs on peripheral smear. A second patient — a 45-year-old with myelofibrosis — also has nucleated RBCs and massive splenomegaly. For each patient, identify the site where blood cells are currently being made, explain how that site relates to the normal developmental sequence of hematopoiesis, and state what has triggered hematopoiesis to occur outside the bone marrow in the adult.

Related topics

RBC Physiology and Lifespan WBC Differential and Function Platelet Physiology and Primary Hemostasis Anemia Approach by MCV

See how your Anki deck covers this topic.

Upload your deck for a free audit →